Concepedia

Amos Adler

AA

Statistics

Publications

108

Citations

6.8K

H-Index

38

Active since

2005

Affiliations

Tel Aviv Sourasky Medical Center(Current)

Tel Aviv University

Israel Ministry of Health

Rambam Health Care Campus

Hebrew University of Jerusalem

Amos Adler is an author at Tel Aviv Sourasky Medical Center specializing in infectious diseases, microbiology, and medical microbiology.

ORCID

Publications per year

2005–2023

108

Publications

108

Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread

Sophia David, Sandra Reuter, Simon R. Harris et al. · Nature Microbiology · 2019 · 818 citations · Full text

, , +14

Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study

Hajo Grundmann, Corinna Glasner, Barbara Albiger et al. · The Lancet Infectious Diseases · 2016 · 677 citations · Full text

, , +16

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

Mical Paul, George L. Daikos, Emanuele Durante‐Mangoni et al. · The Lancet Infectious Diseases · 2018 · 624 citations

, , +14

Multidrug-Resistant <i>Candida haemulonii</i> and <i>C. auris</i> , Tel Aviv, Israel

Ronen Ben‐Ami, Judith Berman, Ana Novikov et al. · Emerging infectious diseases · 2017 · 302 citations · Full text

, , +17

Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study

Abiola Olumuyiwa Olaitan, Seydina M. Diene, Marie Kempf et al. · International Journal of Antimicrobial Agents · 2014 · 278 citations

, , +12

1–5 of 108